These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15634217)

  • 1. Renal transplantation, immunosuppression and the skin: an update.
    Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in transplantation.
    Levy GA
    Ther Drug Monit; 2010 Jun; 32(3):246-9. PubMed ID: 20418803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and evolving immunosuppressive regimens in kidney transplantation.
    Gaston RS
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S3-21. PubMed ID: 16567239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G; Srinivas TR; Meier-Kriesche HU
    Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for minimizing immunosuppression in kidney transplantation.
    Kirk AD; Mannon RB; Swanson SJ; Hale DA
    Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplantation quality of life: more than graft function.
    Habwe VQ
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S98-110. PubMed ID: 16567244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin lesions in renal transplant recipients].
    Myśliwiec H; Chodynicka B; Serwin AB
    Wiad Lek; 2002; 55(3-4):214-20. PubMed ID: 12182007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression and immune monitoring after renal transplantation.
    Zand MS
    Semin Dial; 2005; 18(6):511-9. PubMed ID: 16398715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of immunosuppression.
    Chan GL; Gruber SA; Skjei KL; Canafax DM
    Crit Care Clin; 1990 Oct; 6(4):841-92. PubMed ID: 2265383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatologic findings in renal transplant recipients: Possible effects of immunosuppression regimen and p53 mutations.
    Serdar ZA; Eren PA; Canbakan M; Turan K; Tellioglu G; Gülle S; Ozgezer T; Kara M; Berber I; Titiz MI
    Transplant Proc; 2010 Sep; 42(7):2538-41. PubMed ID: 20832539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression after kidney transplantation: current stragegies and drug interactions.
    Sankari BR; Khauli RB
    J Med Liban; 2004; 52(4):234-40. PubMed ID: 16432988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of skin disease following renal transplantation on quality of life.
    Moloney FJ; Keane S; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2005 Sep; 153(3):574-8. PubMed ID: 16120145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation: the ideal immunosuppression regimen.
    Yabu JM; Vincenti F
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):226-33. PubMed ID: 19576552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal transplantation: evolution in immunosuppression protocols.
    Pirenne J; Kawai M
    Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of systemic immune moderators in dermatology: an update.
    Kazlow Stern D; Tripp JM; Ho VC; Lebwohl M
    Dermatol Clin; 2005 Apr; 23(2):259-300. PubMed ID: 15837155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.